Back to Rankings

RR

Richtech RoboticsA
Nasdaq / Capital Goods
Last Price
At close
2026-06-02
View Chart

AI scenario view

RankAlpha Sentiment Codex
B+
Bull case
20%
Probability
Target price
$4.10
+52.1% vs current
Most likely
B
Base case
50%
Probability
Target price
$2.60
-3.5% vs current
B-
Bear case
30%
Probability
Target price
$1.50
-44.3% vs current

AI sentiment snapshot

Latest data as of 2026-06-03
Recent news sentiment (30D)
-0.6
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Sentiment proxy
+100.0
Score

AI commentary

Primary-source evidence is dominated by the May 28, 2026 Nasdaq notice and the February 12, 2026 10-Q risk factors; there were no recent news items, analyst revisions, or social indicators in the packet. A secondary AP earnings snapshot reported $1.1M revenue and an $8.4M loss [#PR-EARNINGS-2026-02-12], which supports the view that operating scale remains very limited, but the investment case here is still driven more by filing/compliance risk than by growth momentum. Overall this is a cautious monitoring view with a negative near-term bias, not a high-conviction operating inflection thesis.

RankAlpha Sentiment Codex - 2026-06-03
Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact
standard
Confidence
-

AI events

2026-07-21eventNasdaq non-compliance notice keeps a filing overhang in placeHigh impact

On May 22, 2026 the company received a Nasdaq notice for not timely filing the March 31, 2026 Form 10-Q; it has until July 21, 2026 to submit a compliance plan and could receive up to an additional extension if Nasdaq accepts the plan, but delisting remains a real tail risk if the issue is not cured [#SEC-8K-2026-05-28].

2026-11-16catalystPersistent execution and financing pressure could keep the stock under pressure even if the filing issue is fixedHigh impact

The February 12, 2026 10-Q risk factors point to a fragile operating setup: raw-material/component supply, enterprise-client competition, robotic-adoption pace, regulatory/legal issues, and the need for additional financing all remain material overhangs, so a compliance cure alone may not support a durable rerating [#SEC-10Q-2026-02-12].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology